CIK 0001763950 · Non-accelerated filer<br>Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 463973463
- Phone
- 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | Schalop Lee Troy Director | Purchase | +48,544 | $2.06 | $100K | 48,544 |
| 2026-05-12 | Schalop Lee Troy Director | Purchase · Common stock purchase warrant (Right to Buy) | −48,544 | 48,544 | ||
| 2026-05-12 | KEYSER D JEFFREY Director | Purchase | +48,544 | $2.06 | $100K | 94,303 |
| 2026-05-12 | KEYSER D JEFFREY Director | Purchase · Common stock purchase warrant (Right to Buy) | −48,544 | 48,544 | ||
| 2026-01-09 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-01-09 | Silberstein David S. Director | Grant or award · Stock Option (Right to Buy) | +17,307 | 17,307 | ||
| 2026-01-09 | Schalop Lee Troy Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-01-09 | Schalop Lee Troy Director | Grant or award · Stock Option (Right to Buy) | +18,460 | 18,460 | ||
| 2026-01-09 | Maccecchini Maria-Luisa Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-01-09 | Maccecchini Maria-Luisa Director | Grant or award · Stock Option (Right to Buy) | +21,152 | 21,152 | ||
| 2026-01-09 | KEYSER D JEFFREY Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-01-09 | KEYSER D JEFFREY Director | Grant or award · Stock Option (Right to Buy) | +28,844 | 28,844 | ||
| 2026-01-09 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2026-01-09 | Chandru Vijay Director | Grant or award · Stock Option (Right to Buy) | +17,307 | 17,307 | ||
| 2025-12-18 | Margrave David R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-12-18 | Bhatia Kishor G. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-08-19 | Schalop Lee Troy Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-13 | Fletcher Aaron G.L. 10% owner | Sale | −7,206 | $3.09 | $22K | 189,117 |
| 2025-06-13 | Fletcher Aaron G.L. 10% owner | Sale | −12,319 | $3.09 | $38K | 323,335 |
| 2025-06-13 | Fletcher Aaron G.L. 10% owner | Sale | −1,903 | $3.09 | $6K | 49,957 |
Page 1 of 13 · 245 trades